Table 3.
95% CI for B | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Block | F | Δr2 | p-value | Predictor | B | SE | t | p-value | Lower | Upper | Δr2 |
1 | 19.752a | 0.271 | <0.001 | ||||||||
Pre-treatment HDD | 0.440 | 0.050 | 8.877 | <0.001 | 0.342 | 0.537 | 0.216 | ||||
ADS total score | −0.010 | 0.018 | −0.540 | 0.590 | −0.044 | 0.025 | 0.001 | ||||
BAI total score | 0.010 | 0.013 | 0.749 | 0.455 | −0.016 | 0.037 | 0.002 | ||||
AD criteria | 0.069 | 0.065 | 1.071 | 0.285 | −0.058 | 0.197 | 0.003 | ||||
Medication condition | −0.509 | 0.177 | −2.874 | 0.004 | −0.859 | −0.160 | 0.023 | ||||
2 | 0.663b | 0.009 | 0.652 | ||||||||
rs648893 (0 = aa, 1 = ag+gg) | 0.198 | 0.187 | 1.062 | 0.289 | −0.169 | 0.566 | 0.003 | ||||
rs2234918 (0 = aa, 1 = ag+gg) | −0.014 | 0.184 | −0.075 | 0.940 | −0.377 | 0.349 | 0.000 | ||||
rs1799971 (0 = aa, 1 = ag+gg) | 0.191 | 0.187 | 1.023 | 0.307 | −0.177 | 0.560 | 0.003 | ||||
rs678849 (0 = tt, 1 = ct+cc) | −0.121 | 0.203 | −0.597 | 0.551 | −0.520 | 0.278 | 0.001 | ||||
rs963549 (0 = cc, 1 = ct+tt) | −0.227 | 0.204 | −1.113 | 0.267 | −0.628 | 0.174 | 0.003 | ||||
3 | 0.704c | 0.010 | 0.621 | ||||||||
Medication × rs648893 | 0.443 | 0.387 | 1.145 | 0.253 | −0.319 | 1.206 | 0.004 | ||||
Medication × rs2234918 | 0.395 | 0.379 | 1.041 | 0.299 | −0.352 | 1.142 | 0.003 | ||||
Medication × rs1799971 | 0.260 | 0.384 | 0.677 | 0.499 | −0.497 | 1.017 | 0.001 | ||||
Medication × rs678849 | 0.029 | 0.427 | 0.068 | 0.946 | −0.812 | 0.869 | 0.000 | ||||
Medication × rs963549 | −0.284 | 0.412 | −0.689 | 0.491 | −1.095 | 0.527 | 0.001 |
Note. Values represent the effects of the block of interest. Df numerator for all F-ratios = 5; df denominator =
266,
261,
256.
HDD=Heavy Drinking Days Per Week; ADS=Alcohol Dependence Scale; BAI=Beck Anxiety Inventory; AD criteria=current DSM-IV Alcohol Dependence criteria; Medication condition (0 = placebo, 1 = nalmefene).